NRG B-51

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Breast, Breast Neoadjuvant



Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

Eligible for screening study DCP 001


NSABP B-51 is projected to meet accrual goal during the 1st Quarter of 2021.  Closure date pending.

The accrual goal for the Behaviorial and Health Outcomes (BAHO) Quality of Life component in the B-51 trial has been met. Therefore, effective August 6th, 2018, accrual will be closed to the QoL component. The B-51 trial remains open to accrual.

Additional Documents


Leave a Reply